New FDA Guidelines For Abortion Pill Put Women At Risk | American Center for Law and Justice
  Search  |  Login  |  Register

ACLJ Profile Completion

Verified

New FDA Guidelines Put Women At Risk

By ACLJ.org1459534297625

In a move that is devastating to the rights of unborn children and to the health and well-being of their mothers, the Food and Drug Administration (FDA) announced new guidelines this week for how and when the controversial RU486 abortion pill (also known as Mifeprex) can be given.

The new guidelines allow abortionists to prescribe the pill, which facilitates a chemical abortion, much later in pregnancy and with fewer visits by the expectant mother to her physician.

Previously, the FDA guidelines prohibited doctors from giving mothers RU486 past their child’s 7th week of gestation and required three in-office visits to the doctor. The new FDA guidelines have extended that time frame to 10 weeks of gestation and require fewer doctor visits.

This decision has been praised by the abortion industry – which has long lobbied for this change that increases abortion profits – claiming the drug is a safe and effective way for a woman to obtain an abortion.

Yet, abortion is never safe for an unborn child or her mother, and efforts to relax safety standards associated with RU486 will put women at risk. 

By the FDA’s own admission, RU486 can be deadly and cannot be given without medical oversight. The drug’s warning label clearly states that “serious and sometimes fatal infections or bleeding can occur” and the drug must be given under the supervision of a medical professional.

The Director of Education and Research at National Right to Life, Randall O’Bannon, released a statement explaining why the new FDA protocols do not make chemical abortions safer for women.

For women, the mifepristone/misoprostol combination comes with significant cramping, bleeding, and other gastrointestinal side effects (nausea, vomiting, diarrhea) that are expected parts of the chemical abortion process.

While it may be claimed that these side effects are supposed to be reduced with the new protocol, chemical abortions simply do not occur without significant bleeding, cramping, etc. That these side effects are similar to signs of ruptured ectopic pregnancy, serious infection, or may be the prelude to significant hemorrhage that could be missed by patients or even doctors expecting these as part of any chemical abortion would still appear to be a problem under any protocol.

In addition to the substantial medical risks involved with the administration of RU486, women will now be home alone when they undergo the extremely painful chemical abortion and they deliver their 10 week old baby, who very much looks like a human child. Many women will need significant psychological support after undergoing a chemical abortion so late in pregnancy, yet the new FDA regulations refuse to acknowledge this reality.

With the clear risks to the health and well-being of women, it leads us to ask why the FDA felt so compelled to make these changes now?

Dr. O’Bannon commented:

In the end, it is obvious that the FDA’s new protocol serves only the interests of the abortion industry by expanding their base of potential customers, increasing their profit margin, and reducing the level of staff and amount of resources they have to devote to the patient.

It is clear whose interests it is the FDA is serving. It isn’t the women, and it isn’t the babies.

In efforts to protect the health and well-being of women, some states have tried to impose regulations on the use of RU486 – mandating that abortionists actually follow the FDA’s longstanding, stringent guidelines on the use of this dangerous drug, which were often wholly ignored by the abortion industry. Predictably, big abortion and their political allies have fought these safety regulations in court, just as they fight safety standards for abortion clinics passed into law in states like Texas.

Now big abortion has undercut these commonsense safety regulations by successfully pressuring the FDA to drastically reduce its safety guidelines.

These new FDA regulations are part and parcel of this pro-abortion agenda. Once again, big abortion is trying to push for more abortions so they can increase their profits while fighting against laws and regulations that actually look out for the safety and well-being of women.

We will not back down from our fight – in nearly a dozen pro-life cases nationwide – to defend the unborn, ensure the rights of pro-life advocates are upheld, and protect the health and safety of women.

Defeat the Abortion-Pill Mandate

Religious Liberty  Signatures

LOGIN

Receive the latest news, updates, and contribution opportunities from ACLJ.

$20
$40
$60
$120
$240
Make this a monthly tax-deductible gift.

As we file a major Supreme Court amicus brief to defeat the abortion-pill mandate, take and have your gift doubled today.

Email Address is required.
First Name is required.
Last Name is required.
Credit Card Number is required.
Verification Code is required.
Expiration Month is required.
Expiration Year is required.
Receive the latest news, updates, and contribution opportunities from ACLJ.
Encourage your friends to sign and donate by sharing this petition.
Latest in
Pro Life

Supreme Court To Hear Challenge To Rule Blocking Planned Parenthood

By Jordan Sekulow1614265140000

A pro-life rule that we fought for – AND YOU DID TOO – is under attack. When the Department of Health and Human Services (HHS) issued a rule blocking millions of our tax dollars from abortionists, Planned Parenthood stomped away from the program. But with the new Biden Administration in power, the...

read more

ACLJ Urges UN Human Rights Council To Denounce Infanticide Worldwide

By CeCe Heil1614183205574

It’s high time the world takes action to stop the torture of the most defenseless and vulnerable – unborn babies. Over the past year, the majority of the world has agreed to take special precautions in order to protect the “most vulnerable” – specifically the elderly and immunocompromised – who are...

read more

ACLJ Joins Letter for Senate to Oppose Pro-Abortion Nominee Becerra

By Jordan Sekulow1614092340000

As the Executive Director of the ACLJ, I am joining other pro-life leaders in signing a letter to the U.S. Senate Committee on Health, Education, Labor, and Pensions in opposition to the nomination of Xavier Becerra to serve as the next Secretary of the Department of Health and Human Services...

read more

Biden Nominee Xavier Becerra Could Be the Most Pro-Abortion Ever

By Olivia Summers1613573460000

President Biden has acted swiftly to undo many of the pro-life actions that were taken by the Trump Administration. But none may be more detrimental to the cause of protecting the unborn than his nominee to be the next Secretary of Health and Human Services (HHS) – California Attorney General...

read more